ImKTx1, a new Kv1.3 channel blocker with a unique primary structure

Journal of Biochemical and Molecular Toxicology

Volumn 25, Issue 4, 2011, Pages 244-251

  Chen, Zongyun ^a   Hu, Youtian ^a   Han, Song ^a   Yin, Shijin ^b   He, Yawen ^a   Wu, Yingliang ^a   Cao, Zhijian ^a   Li, Wenxin ^a  

^a WUHAN UNIVERSITY   (China)

^b SOUTH CENTRAL UNIVERSITY FOR NATIONALITIES   (China)

Author keywords

ImKTx1; Isometrus maculates; Kv1.3 Channel; Scorpion toxin peptide; Venom peptide

Indexed keywords

CALCIUM CHANNEL; COMPLEMENTARY DNA; CYSTEINE; POTASSIUM CHANNEL; POTASSIUM CHANNEL BLOCKING AGENT; POTASSIUM CHANNEL KV1.1; POTASSIUM CHANNEL KV1.2; POTASSIUM CHANNEL KV1.3; RECOMBINANT IMKTX1 PEPTIDE; SODIUM CHANNEL NAV1.2; SODIUM CHANNEL NAV1.4; TOXIN; UNCLASSIFIED DRUG; VENOM;

AMINO ACID SEQUENCE; ARTICLE; DNA LIBRARY; ELECTROPHYSIOLOGY; GENE ISOLATION; IC 50; ISOMETRUS MACULATES; NONHUMAN; SCORPION; SEQUENCE ALIGNMENT; SPIDER;

AMINO ACID SEQUENCE; ANIMALS; BASE SEQUENCE; CLONING, MOLECULAR; HEK293 CELLS; HUMANS; KV1.3 POTASSIUM CHANNEL; MEMBRANE POTENTIALS; MOLECULAR SEQUENCE DATA; PATCH-CLAMP TECHNIQUES; PEPTIDES; PROTEIN STRUCTURE, SECONDARY; SCORPION VENOMS; SCORPIONS; SEQUENCE ANALYSIS, DNA;

ARANEAE; SCORPIONES;

EID: 79961029201     PISSN: 10956670     EISSN: 10990461     Source Type: Journal    
DOI: 10.1002/jbt.20382     Document Type: Article

References (32)

1. + channels. Ann N Y Acad Sci 1999; 868:233-285.
2. + channel modulators for the treatment of neurological disorders and autoimmune diseases. Chem Rev 2008; 108(5): 1744-1773.
3. Beeton C, Wulff H, Standifer NE, Azam P, Mullen KM, Pennington MW, Kolski-Andreaco A, Wei E, Grino A, Counts DR, and others. Kv1.3 channels are a therapeutic target for T cell-mediated autoimmune diseases. Proc Natl Acad Sci U S A 2006; 103(46): 17414-17419.
4. + channels and inhibits T lymphocyte proliferation. J Biol Chem 2008; 283(2): 988-997.
5. Beeton C, Pennington MW, Wulff H, Singh S, Nugent D, Crossley G, Khaytin I, Calabresi PA, Chen CY, Gutman GA, Chandy KG. Targeting effector memory T cells with a selective peptide inhibitor of Kv1.3 channels for therapy of autoimmune diseases. Mol Pharmacol 2005; 67(4): 1369-1381.
6. + channels improves experimental autoimmune encephalomyelitis and inhibits T cell activation. J Immunol 2001; 166(2): 936-944.
7. Froy O, Sagiv T, Poreh M, Urbach D, Zilberberg N, Gurevitz M. Dynamic diversification from a putative common ancestor of scorpion toxins affecting sodium, potassium, and chloride channels. J Mol Evol 1999; 48(2): 187-196.
8. Dehesa-Davila M, Possani LD. Scorpionism and serotherapy in Mexico. Toxicon 1994; 32(9): 1015-1018.
9. Tytgat J, Chandy KG, Garcia ML, Gutman GA, Martin-Eauclaire MF, Van Der Walt JJ, Possani LD. A unified nomenclature for short-chain peptides isolated from scorpion venoms: alpha-KTx molecular subfamilies. Trends Pharmacol Sci 1999; 20(11): 444-447.
10. +-channels. Toxicon 2004; 43(8): 865-875.
11. Zeng XC, Luo F, Li WX. Molecular dissection of venom from Chinese scorpion Mesobuthus martensii: identification and characterization of four novel disulfide-bridged venom peptides. Peptides 2006; 27(7): 1745-1754.
12. Han S, Yi H, Yin SJ, Chen ZY, Liu H, Cao ZJ, Wu YL, Li WX. Structural basis of a potent peptide inhibitor designed for Kv1.3 channel, a therapeutic target of autoimmune disease. J Biol Chem 2008; 283(27): 19058-19065.
13. Tenenholz TC, Klenk KC, Matteson DR, Blaustein MP, Weber DJ. Structural determinants of scorpion toxin affinity: the charybdotoxin (alpha-KTX) family of K(+)-channel blocking peptides. Rev Physiol Biochem Pharmacol 2000; 140:135-185.
14. Shijin Y, Hong Y, Yibao M, Zongyun C, Han S, Yingliang W, Zhijian C, Wenxin L. Characterization of a new Kv1.3 channel-specific blocker, J123, from the scorpion Buthus martensii Karsch. Peptides 2008; 29(9): 1514-1520.
15. Zhijian C, Yun X, Chao D, Shunyi Z, Shijin Y, Yingliang W, Wenxin L. Cloning and characterization of a novel calcium channel toxin-like gene BmCa1 from Chinese scorpion Mesobuthus martensii Karsch. Peptides 2006; 27(6): 1235-1240.
16. Wu W, Yin S, Ma Y, Wu YL, Zhao R, Gan G, Ding J, Cao Z, Li W. Molecular cloning and electrophysiological studies on the first K(+) channel toxin (LmKTx8) derived from scorpion Lychas mucronatus. Peptides 2007; 28(12): 2306-2312.
17. Bendtsen JD, Nielsen H, von Heijne G, Brunak S. Improved prediction of signal peptides: SignalP 3.0. J Mol Biol 2004; 340(4): 783-795.
18. Larkin MA, Blackshields G, Brown NP, Chenna R, McGettigan PA, McWilliam H, Valentin F, Wallace IM, Wilm A, Lopez R, Thompson JD, Gibson TJ, Higgins DG. Clustal W and Clustal X version 2.0. Bioinformatics 2007; 23(21): 2947-2948.
19. + ion channels effector toxins. BMC Pharmacol 2009; 9: 4.
20. Kopp J, Schwede T. The SWISS-MODEL Repository of annotated three-dimensional protein structure homology models. Nucleic Acids Res 2004; 32(Database issue): D230-D234.
21. Schwede T, Kopp J, Guex N, Peitsch MC. SWISS-MODEL: An automated protein homology-modeling server. Nucleic Acids Res 2003; 31(13): 3381-3385.
22. Huys I, Dyason K, Waelkens E, Verdonck F, van Zyl J, du Plessis J, Müller GJ, Van Der Walt J, Clynen E, Schoofs L, Tytgat J. Purification, characterization and biosynthesis of parabutoxin 3, a component of Parabuthus transvaalicus venom. Eur J Biochem 2002; 269(7): 1854-1865.
23. Regaya I, Beeton C, Ferrat G, Andreotti N, Darbon H, De Waard M, Sabatier JM. Evidence for domain-specific recognition of SK and Kv channels by MTX and HsTx1 scorpion toxins. J Biol Chem 2004; 279(53): 55690-55696.
24. 2+ channel. J Mol Biol 2002; 321(3): 517-526.
25. + channel blockers: novel tools to inhibit T cell activation leading to specific immunosuppression. Curr Pharm Des 2006; 12(18): 2199-2220.
26. + channels depolarize human T lymphocytes: mechanism of the antiproliferative effect of charybdotoxin. Proc Natl Acad Sci U S A 1992; 89(21): 10094-10098.
27. Mouhat S, Teodorescu G, Homerick D, Visan V, Wulff H, Wu Y, Grissmer S, Darbon H, De Waard M, Sabatier JM. Pharmacological profiling of Orthochirus scrobiculosus toxin 1 analogs with a trimmed N-terminal domain. Mol Pharmacol 2006; 69(1): 354-362.
28. + channel types targeted by synthetic OSK1, a toxin from Orthochirus scrobiculosus scorpion venom. Biochem J 2005; 385(Pt 1): 95-104.
29. + channels as targets for specific immunomodulation. Trends Pharmacol Sci 2004; 25(5): 280-289.
30. + channels. Biochem J 2005; 388(Pt 2): 455-464.
31. + channels and scorpion toxins. Trends Pharmacol Sci 2003; 24(5): 222-227.
32. + channel with its specific BeKm-1 peptide: insights into the selectivity of molecular recognition. J Proteome Res 2007; 6(2): 611-620.